Trends and Variations in Concurrent Dispensing of Prescription Opioids and Benzodiazepines in Australia: A Retrospective Analysis

@article{Islam2020TrendsAV,
  title={Trends and Variations in Concurrent Dispensing of Prescription Opioids and Benzodiazepines in Australia: A Retrospective Analysis},
  author={M Mofizul Islam and Dennis Wollersheim},
  journal={Contemporary Drug Problems},
  year={2020},
  volume={47},
  pages={136 - 148}
}
Objective: Concurrent use of opioids and benzodiazepines may cause a range of adverse health outcomes including fatal overdose. However, little is known about levels of concurrent use and its variation across jurisdictions. This study examined the population-level prevalence of concurrent use in Australia. Methods: We analyzed a 10% sample of unit record data of prescription opioids and benzodiazepines dispensed between January 2013 and December 2016. Using dispensing dates and days of supply… 

Figures and Tables from this paper

References

SHOWING 1-10 OF 59 REFERENCES
Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis
TLDR
From 2001 to 2013, concurrent benzodiazepine/opioid use sharply increased in a large sample of privately insured patients in the US and significantly contributed to the overall population risk of opioid overdose.
A comparison of opioids and benzodiazepines dispensing in Australia
TLDR
Clients with a history of dispensing of one of these two medicines were significantly more likely to have dispensed the other for a relatively long period, and consistent use of real-time drug monitoring program and tailored intervention are recommended.
Cohort Study of the Impact of High-Dose Opioid Analgesics on Overdose Mortality.
TLDR
Dose-dependent opioid overdose risk among patients increased gradually and did not show evidence of a distinct risk threshold, suggesting there is urgent need for guidance about combined classes of medicines to facilitate a better balance between pain relief and overdose risk.
Opioid dose and drug-related mortality in patients with nonmalignant pain.
TLDR
Among patients receiving opioids for nonmalignant pain, the daily dose is strongly associated with opioid-related mortality, particularly at doses exceeding thresholds recommended in recent clinical guidelines.
Exposure-Response Association Between Concurrent Opioid and Benzodiazepine Use and Risk of Opioid-Related Overdose in Medicare Part D Beneficiaries
TLDR
Policy interventions should focus on preventing concurrent opioid and benzodiazepine use in the first place instead of reducing the length of concurrent use.
Emergency Department Visits and Overdose Deaths From Combined Use of Opioids and Benzodiazepines.
The risk and benefit of benzodiazepine use in patients with chronic pain.
TLDR
The authors concluded that patients with chronic pain using benzodiazepines on a daily basis are a particularly high-risk group and that the high rate of Benzodiazepine use in this patient population is not consistent with accepted guidelines on safe opioid prescribing.
Sex differences in the risk of receiving potentially inappropriate prescriptions among older adults
TLDR
There are significant sex differences in older adults' risk of receiving a potentially inappropriate prescription as a result of complex intersections between gender and other social constructs.
...
...